Top Key Companies for NGS Sequencers Market: Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies, Gene, Roche, Beckman Coulter, PerkinElmer, GTH.O, Boao Bio Group, Oxford Nanopore Technologies.
Global NGS Sequencers Market Size was estimated at USD 284.5 million in 2022 and is projected to reach USD 1286.85 million by 2028, exhibiting a CAGR of 28.6% during the forecast period.
Global NGS Sequencers Market Overview And Scope:
The Global NGS Sequencers Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of NGS Sequencers utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global NGS Sequencers Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NGS Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global NGS Sequencers market.
Global NGS Sequencers Market Segmentation
By Type, NGS Sequencers market has been segmented into:
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
By Application, NGS Sequencers market has been segmented into:
Hospitals and Clinics
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Other
Regional Analysis of NGS Sequencers Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of NGS Sequencers Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The NGS Sequencers market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the NGS Sequencers market.
Top Key Companies Covered in NGS Sequencers market are:
Illumina Inc.
BioMérieux
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
BGI
PacBio
Agilent Technologies
Gene
Roche
Beckman Coulter
PerkinElmer
GTH.O
Boao Bio Group
Oxford Nanopore Technologies
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: NGS Sequencers Market by Type
5.1 NGS Sequencers Market Overview Snapshot and Growth Engine
5.2 NGS Sequencers Market Overview
5.3 Reversible End Termination Sequencing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Reversible End Termination Sequencing: Geographic Segmentation
5.4 Semiconductor Sequencing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Semiconductor Sequencing: Geographic Segmentation
5.5 Combined Probe Anchored Polymerization Sequencing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Combined Probe Anchored Polymerization Sequencing: Geographic Segmentation
Chapter 6: NGS Sequencers Market by Application
6.1 NGS Sequencers Market Overview Snapshot and Growth Engine
6.2 NGS Sequencers Market Overview
6.3 Hospitals and Clinics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals and Clinics: Geographic Segmentation
6.4 Academic and Research Institutions
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Academic and Research Institutions: Geographic Segmentation
6.5 Pharmaceutical and Biotech Companies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Pharmaceutical and Biotech Companies: Geographic Segmentation
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 NGS Sequencers Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 NGS Sequencers Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 NGS Sequencers Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ILLUMINA INC.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BIOMÉRIEUX
7.4 LIFE TECHNOLOGIES CORPORATION
7.5 THERMO FISHER SCIENTIFIC
7.6 MEMORIAL SLOAN KETTERING
7.7 BGI
7.8 PACBIO
7.9 AGILENT TECHNOLOGIES
7.10 GENE
7.11 ROCHE
7.12 BECKMAN COULTER
7.13 PERKINELMER
7.14 GTH.O
7.15 BOAO BIO GROUP
7.16 OXFORD NANOPORE TECHNOLOGIES
Chapter 8: Global NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Reversible End Termination Sequencing
8.2.2 Semiconductor Sequencing
8.2.3 Combined Probe Anchored Polymerization Sequencing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals and Clinics
8.3.2 Academic and Research Institutions
8.3.3 Pharmaceutical and Biotech Companies
8.3.4 Other
Chapter 9: North America NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Reversible End Termination Sequencing
9.4.2 Semiconductor Sequencing
9.4.3 Combined Probe Anchored Polymerization Sequencing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals and Clinics
9.5.2 Academic and Research Institutions
9.5.3 Pharmaceutical and Biotech Companies
9.5.4 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Reversible End Termination Sequencing
10.4.2 Semiconductor Sequencing
10.4.3 Combined Probe Anchored Polymerization Sequencing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals and Clinics
10.5.2 Academic and Research Institutions
10.5.3 Pharmaceutical and Biotech Companies
10.5.4 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Reversible End Termination Sequencing
11.4.2 Semiconductor Sequencing
11.4.3 Combined Probe Anchored Polymerization Sequencing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals and Clinics
11.5.2 Academic and Research Institutions
11.5.3 Pharmaceutical and Biotech Companies
11.5.4 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Reversible End Termination Sequencing
12.4.2 Semiconductor Sequencing
12.4.3 Combined Probe Anchored Polymerization Sequencing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals and Clinics
12.5.2 Academic and Research Institutions
12.5.3 Pharmaceutical and Biotech Companies
12.5.4 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Reversible End Termination Sequencing
13.4.2 Semiconductor Sequencing
13.4.3 Combined Probe Anchored Polymerization Sequencing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals and Clinics
13.5.2 Academic and Research Institutions
13.5.3 Pharmaceutical and Biotech Companies
13.5.4 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America NGS Sequencers Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Reversible End Termination Sequencing
14.4.2 Semiconductor Sequencing
14.4.3 Combined Probe Anchored Polymerization Sequencing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals and Clinics
14.5.2 Academic and Research Institutions
14.5.3 Pharmaceutical and Biotech Companies
14.5.4 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
NGS Sequencers Scope:
|
Report Data
|
NGS Sequencers Market
|
|
NGS Sequencers Market Size in 2025
|
USD XX million
|
|
NGS Sequencers CAGR 2025 - 2032
|
XX%
|
|
NGS Sequencers Base Year
|
2024
|
|
NGS Sequencers Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies, Gene, Roche, Beckman Coulter, PerkinElmer, GTH.O, Boao Bio Group, Oxford Nanopore Technologies.
|
|
Key Segments
|
By Type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
By Applications
Hospitals and Clinics
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Other
|
